Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-116
CJC-1295 (no DAC) 5 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-116
Active Batch Lot
GH Secretagogues & Growth Factors • In stock — Ready to ship

CJC-1295 (no DAC) (5 mg)

€44 5 mg • EUR
Related Formats: CJC-1295 (no DAC) (5 mg) CJC-1295 (5 mg) — €48

CJC-1295 No DAC (Modified GRF 1-29) is a tetrasubstituted 29-amino acid GHRH analogue (D-Ala2, Gln8, Ala15, Leu27) engineered for DPP-4 enzymatic resistance and pulsatile somatotroph receptor signaling (~30 min half-life).

Chemical & Registry Specifications
CAS Registry Number 863288-34-0
Molecular Formula C152H252N44O42
Molecular Weight 3367.97 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Primary Biological Target / Pathway Pituitary GHRH Receptor (Class B GPCR)
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: CJC-1295 (no DAC)

CJC-1295 No DAC (Modified GRF 1-29) is a tetrasubstituted 29-amino acid GHRH analogue (D-Ala2, Gln8, Ala15, Leu27) engineered for DPP-4 enzymatic resistance and pulsatile somatotroph receptor signaling (~30 min half-life).

Exact 4-point DPP-4-resistant GHRH(1-29) sequence
Distinct from DAC form — models short pulsatile GH release
ESI-MS confirmed at 3367.97 Da (≥99.0% HPLC)
Primary Literature Reference Jetté L. et al., Endocrinology (2005) — Tetrasubstituted GHRH(1-29) resistance to DPP-4 enzymatic cleavage (PMID: 15817669)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-116)

Analytical release verification for current CJC-1295 (no DAC) (5 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-116 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.0% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL)

Temperature & Stability

Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C for up to 28 days.

CJC-1295 (no DAC) — Technical Questions & Answers

What is the molar concentration when reconstituting CJC-1295 (no DAC) (5 mg) in 2.0 mL?

Reconstituting the full 5 mg vial of CJC-1295 (no DAC) (MW 3367.97 g/mol) in 2.0 mL of diluent produces a 2.50 mg/mL stock solution — equivalent to approximately 0.74 mM (742 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does CJC-1295 (no DAC)'s counterion stoichiometry affect assay mass calculations?

CJC-1295 (no DAC) (CAS 863288-34-0, formula C152H252N44O42) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify CJC-1295 (no DAC) Lot SL-2026-116 and what pathway does it target?

Lot SL-2026-116 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 3367.97 g/mol. In preclinical literature, CJC-1295 (no DAC) targets Pituitary GHRH Receptor (Class B GPCR) (Jetté L. et al., Endocrinology (2005) — Tetrasubstituted GHRH(1-29) resistance to DPP-4 enzymatic cleavage (PMID: 15817669)).

Research Use Only (RUO): CJC-1295 (no DAC) is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related GH Secretagogues & Growth Factors Compounds

View category →
≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 5 mg — ≥99.0% Research Vial
CJC-1295
5 mg In stock
CAS 863288-34-0 (with DAC)
MW: 3647.28 g/mol
€48
≥99.0%
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% Research Vial
CJC-1295 + Ipamorelin
5mg + 5mg In stock
CAS 863288-34-0 / 170851-70-4
MW: 3367.97 g/mol & 711.86 g/mol
€62
≥99.0%
Follistatin 1 mg — ≥99.0% Research Vial
Follistatin
1 mg In stock
CAS 117628-82-7
MW: ~34.8 kDa (non-glycosylated core)
€82

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog